C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

Katsuichi Miyamoto, Sachiko Miyake, Takashi Yamamura · Nature · 2001 · 864 citations

Inflammation, Autoimmune Disease, Allergy +12

Experimental Autoimmune Encephalomyelitis (EAE) in CCR2−/− Mice

Stefanie Gaupp, David Pitt, William A. Kuziel et al. · American Journal Of Pathology · 2003 · 129 citations · Full text

Autoimmune Disease, Immune Cell Development, Immune Regulation +10

CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis

Yuanfan Wang, Long Cui, Waldemar Gonsiorek et al. · Journal of Inflammation · 2009 · 55 citations · Full text

Core exploration in optimization of chemokine receptor CCR4 antagonists

Ashok V. Purandare, Honghe Wan, John E. Somerville et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 43 citations · Full text

Functional Selectivity, Medicine, Rational Drug Design +4

Selective down‐regulation of <scp>Th</scp>2 cell‐mediated airway inflammation in mice by pharmacological intervention of <scp>CCR</scp>4

Osamu Kaminuma, Takayuki Ohtomo, Akio Mori et al. · Clinical & Experimental Allergy · 2011 · 35 citations · Full text